Gynopedia needs your support! Please consider contributing content, translating a page, or making a donation today. With your support, we can sustain and expand the website. Gynopedia has no corporate sponsors or advertisers. Your support is crucial and deeply appreciated.
Paris: Difference between revisions
Jump to navigation
Jump to search
→Laws & Social Stigmas
(→Testing Facilities: misprint) |
|||
| Line 69: | Line 69: | ||
Regarding HPV, according to the HPV Information Centre, it's estimated that 4.7% of French women are infected with HPV-16/18. Furthermore, 75.6% of invasive cervical cancer cases in France are attributed to HPV 16 or HPV 18. Fortunately, the country has a nationwide vaccination program.<ref>[http://www.hpvcentre.net/statistics/reports/FRA_FS.pdf France: Human Papillomavirus and Related Cancers, Fact Sheet 2016]</ref> | Regarding HPV, according to the HPV Information Centre, it's estimated that 4.7% of French women are infected with HPV-16/18. Furthermore, 75.6% of invasive cervical cancer cases in France are attributed to HPV 16 or HPV 18. Fortunately, the country has a nationwide vaccination program.<ref>[http://www.hpvcentre.net/statistics/reports/FRA_FS.pdf France: Human Papillomavirus and Related Cancers, Fact Sheet 2016]</ref> | ||
In French, AIDS is "SIDA" (Syndrome d'immunodéficience acquise), HIV is "VIH" (Virus de l'immunodéficience humaine) and HIV-positive person is "séropositif" (male) or "séropositive" (female). | |||
===Testing Facilities=== | ===Testing Facilities=== | ||